Catalyst Wire Dossier Catalyst Wire Dossier

OTI-010

· Mesoblast International Sàrl
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OTI-010, covering 2014-12-04 to 2014-12-04. Get the full timeline:

Most recent: Clinical Trial Update: OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies [Phase 2]

See pricing